Generic drugmakers have seen profits shrink due to intensifying pricing pressure on the low-cost pharmaceuticals.
Reuters, St. Louis Post-Dispatch: Business
Fri, 04/20/2018 - 10:24am
Generic drugmakers have seen profits shrink due to intensifying pricing pressure on the low-cost pharmaceuticals.